Bernd Winterhalter, MD, PhD


Interim Chief Development Officer

Bernd Winterhalter, MD, PhD is as consultant and interim manager with CureVac since June 2018 and our interim Chief Development Officer since December 2019.

Previously, he was the Executive Medical Director European Markets, Turkey & Russia of Bristol-Myers Squibb from 2012 until 2018 and Executive Medical Director Germany from 2004 to 2011, where he successfully contributed to the clinical development and market introduction of 15 new products in multiple therapeutic areas, as well as Vice President Medical & Science and Health Economics at Pharmacia (Pfizer) Germany from 1997 until 2003.

Earlier in his career, Dr. Winterhalter worked as ward physician at the Department Internal Medicine I (medical oncology and hematology) University Hospital Albert Ludwigs University Freiburg. He is a board certified specialist internal medicine since 1993 and received his medical registration (approbation) and MD degree in 1986 as well as his PhD (Doctoral degree) from Albert Ludwigs University Freiburg.

Back to Executive Board